Navigation Links
Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder

National Autism Association calls 2006 Pediatrics study fatally flawed

CHICAGO, March 07, 2007 /PRNewswire-USNewswire/ -- New findings presented yesterday at a National Autism Association meeting bolster claims that vaccines may play a role in the development of autism spectrum disorders. David Ayoub, MD presented data suggesting a correlation between mercury- containing vaccines and rates of pervasive developmental disorder (PDD), a form of autism, in Montreal. The peak rate of one in 87 children diagnosed with PDD occurred following the period of greatest exposure to the mercury- based vaccine preservative thimerosal. A flattening of the rates studied is now emerging as mercury-containing vaccines have been gradually eliminated from the routine schedule.

This new data points out flaws in a 2006 study published in the journal Pediatrics by Eric Fombonne, MD, et al, which found PDD rates continued to increase even when rates of MMR vaccination and use of mercury-containing vaccines decreased. The study population consisted of a single Montreal school board that was an Autism Center of Excellence, suggesting an over- ascertainment of regional diagnoses. Dr. Ayoub and co-authors Monica Ruscitti, BA, and F. Edward Yazbak, MD broadened the data to include all five Montreal school boards.

The earlier study also reported PDD rates in children from Montreal, but MMR coverage data was taken from Quebec City located 265km from Montreal. The researchers confirmed MMR coverage rates actually increased in Montreal along with PDD, noting a sharper rise in rates after the number of required MMR shots doubled.

The Pediatrics paper claimed there was no exposure to mercury from vaccines post-1996 although several mercury-containing vaccines were administered well beyond 1996. "It's irresponsible that such flawed data was published in a medical journal. This new information confirms a relationship between va
'"/>




Page: 1 2

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
2. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
3. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
4. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
6. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
7. ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
8. MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
9. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
10. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:7/28/2015)... , July 28, 2015  SeraCare Life ... diagnostics manufacturers, announced today at the American Association ... signed a licensing agreement with the University of ... Trisomy 21 (T21), Trisomy 18 (T18) and Trisomy ... component for creating "patient-like" reference materials for Non-Invasive ...
(Date:7/28/2015)... Texas , July 28, 2015 ... Dermatology Devices Market by Type (Dermatology Treatment Devices, and ... Dermatoscopes, Microscopes]), by Application, by Geography - Analysis and ... expected to reach $11.88 billion by 2019, at a ... Browse through the TOC of Global Dermatology Devices Market ...
(Date:7/28/2015)... Fla. , July 28, 2015  For many ... their researchers, physicians and other inventors can be a ... market is difficult, and successes are rare. ... wants to change that. Medical Device Investments ... licensed from universities, hospitals and physicians. MDI develops, manufactures ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
(Date:7/29/2015)... Scottsdale, Arizona (PRWEB) , ... July 29, 2015 , ... ... residential dorms. The project, which will by the end will cost the 501(c) organization ... compliance of Arizona’s recent anti-ligature requirements. , “We took it down to the ...
(Date:7/29/2015)... Hoffman Estates, IL (PRWEB) , ... July 29, 2015 , ... ... can both benefit from two new products on Mercola.com: a vertical “garden tower” and ... – which can be squeezed into small corners on a porch, balcony, or rooftop ...
(Date:7/29/2015)... ... ... Hernia repairs have always been common and routine surgical procedures and technologies ... Center for Health Statistics indicates that more than five million Americans currently suffer from ... only effective treatment for a hernia is surgery, only about 750,000 Americans will actually ...
(Date:7/28/2015)... VA (PRWEB) , ... July 29, 2015 , ... Talking ... Aug. 18, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , ... they can — and can’t — say about it is tightly regulated by the ...
(Date:7/28/2015)... ... July 28, 2015 , ... Jordan Valley Medical ... With The Guidelines®-Stroke Gold Plus Award for implementing specific quality improvement measures outline ... , The Get With The Guidelines-Stroke program recognizes hospitals that demonstrate at least ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3
... A simple and an affordable follow-up test to identify ... to their first chemotherapy regimen, // has been developed ... children who have a good response may then be ... up visits. ,This new test is based ...
... center in Houston stated yesterday that ultrasound is fast becoming ... pregnant woman. // ,Dr. Wei Yang of ... to educate young women that the symptomatic breast cancer that ... pregnant, and so they should not wait to seek medical ...
... Center are embarking on a study to gauge if ... many cancer survivors after chemotherapy.// The study is being ... and athlete, Lance Armstrong. ,Charles Matthews, Ph.D., ... and Psychiatry, will lead a team of researchers at ...
... Rayburn, a cardiologist from the University of Alabama, Birmingham, told ... the drug showed no significant difference in the rate of ... or placebos. The drug Vioxx is produced and marketed by ... told a jury that the studies, covering a total of ...
... venom can be used for easing the debilitating pain from ... at the Shulov Institute of Sciences (SIS) in Israel where ... based on snake venom could be on sale within five ... - the most common snake in Israel - and said ...
... Minister Manmohan Singh has announced the launch of an ... in order to train around 5,000 public health professionals. ... healthcare between the rich and the poorer sections of ... Public Health Foundation of India (PHFI), also aims to ...
Cached Medicine News:Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 2Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 3Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2
... with polished metal rims in an elegant ... to 20.00 Diopters (0.25D increments) , ,70 ... (0.25D increments), ,34 Cylindrical Concave Lenses: 0.12 ... Convex Lenses: 0.12 to 6.00 Diopters (0.25D ...
... Ultramatic Rx Master is designed ... of reliable service and give ... measurably improve procedures. It embodies ... and want most, including accuracy, ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... The Illuminated Phoroptor features lighted dials to ... perform refractions in the darkened setting of ... light and leave the lights off throughout ... lighted sphere, cylinder power and cylinder axis ...
Medicine Products: